Analgesia

Ward · prescribing

Analgesia

Step 1

Ladder

  • 1 · base, regular: paracetamol ± NSAID
  • 2 · weak opioid: tramadol
  • 3 · strong opioid: morphine, oxycodone
  • add an adjuvant at any step for neuropathic pain
Step 2

Doses

drugdosecaution
Paracetamol1 g QDS (max 4 g/day)reduce if < 50 kg, frail, or liver disease
Ibuprofen400 mg TDS (max 2.4 g/day)avoid in AKI, GI bleed risk, cardiac, elderly
Ketorolac10–30 mg IV/IM (max 90 mg/day; 60 mg if elderly or < 50 kg; max 5 days)NSAID cautions; short-term only
Tramadol50–100 mg QDS (max 400 mg/day)serotonergic, lowers seizure threshold, caution in elderly
Morphine (oral IR)5–10 mg PRN (2.5–5 mg if frail / renal)see renal note
Morphine (IV)2–5 mg, titrated in 1–2 mg incrementsmonitor sedation + RR
Step 3

Conversion

approximate: verify against local / palliative guidance

from → tofactor
Tramadol → oral morphine÷ 10 (approx)
oral morphine → oral oxycodone÷ 1.5–2
oral morphine → SC morphine÷ 2
oral morphine → SC diamorphine÷ 3
  • Breakthrough dose = 1/6 of the total 24-hour opioid dose
Step 4

Renal

  • Avoid morphine and codeine: active metabolites (M6G) accumulate, giving sedation and respiratory depression. Avoid below a creatinine clearance of about 30 mL/min
  • Prefer fentanyl or alfentanil (specialist hands), or oxycodone with dose reduction and monitoring
  • Reduce all doses and lengthen intervals
Step 5

Co-prescribe

  • A laxative: opioids constipate predictably
  • A PRN antiemetic
  • Naloxone available for toxicity
    • Ward opioid toxicity / opioid-dependent: 100 mcg (0.1 mg) IV, repeat every 2–3 min, titrate to respiratory rate > 12 (not to full alertness)
    • Severe respiratory depression / peri-arrest: 400 mcg (0.4 mg) IV/IM, repeat every 2–3 min; no IV/IM access: 2 mg intranasal
    • Recurrent depression → infusion at approximately two-thirds of the effective bolus dose per hour

Neuropathic pain

  • Amitriptyline, gabapentin / pregabalin, or duloxetine: first-line over opioids
Step 6

Safety

Opioid toxicity

  • Falling respiratory rate or rising sedation score → hold the opioid, reassess, naloxone if toxic

Naloxone wears off before the opioid does

  • Respiratory depression recurs as naloxone washes out: keep monitoring well beyond the dose, longer after modified-release opioids, methadone or a patch
  • Repeat doses needed → infusion + higher-level monitoring; doses in Step 5

Two more traps

  • Gabapentinoids with opioids: serious respiratory depression. Highest risk if age ≥ 65, COPD, renal impairment, or concurrent benzodiazepines
  • Combination tablets: count the paracetamol they contain toward the daily maximum

On-call approach

Pain uncontrolled on current analgesia: the bedside approach when the regimen is not working.

Last clinically reviewed · June 2026 · Last updated · October 2026

Verify indication, dose, allergies, interactions, renal/hepatic function and local protocols before prescribing.